Effects of Freeze-dried Grape Powder on Immune Profiles in Healthy Aging Adults

Last updated: July 25, 2025
Sponsor: University of Connecticut
Overall Status: Active - Recruiting

Phase

N/A

Condition

Inflammation

Treatment

Freeze-dried whole grape powder

Control grape-free powder

Clinical Study ID

NCT07079982
B2024-0072/24-02-508-910
  • Ages 50-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to investigate the effects of consuming grape powder on immune profiles in healthy middle- and older-aged individuals. Specifically, the investigators are interested in evaluating the potential effects of grapes in influencing markers of immune function, inflammation, and metabolism that are known to change with aging. Grapes contain several nutrients and antioxidant polyphenols such as resveratrol, quercetin, vitamin K and fiber, which are known to promote heart and immune health. However, the effects of grapes on altering immune profiles within the context of aging is not well understood. Therefore, this study will explore how daily grape consumption impacts certain markers of immunity in healthy middle- and older-aged adults.

The main study procedures include consumption of a freeze-dried grape powder and control powder (which tastes the same but has none of the grape compounds that are being studied) mixed with water as a beverage on a daily basis for 4 weeks each. The investigators will additionally ask that participants avoid eating grapes and certain other antioxidant/grape-related foods and beverages throughout the 13-week study. Participants will additionally be asked to complete surveys about their diet, physical activity, and medical history, as well as provide blood samples and body weight measures throughout the course of the study. Participation in the study is expected to last about 6.25 hours over the course of 13 weeks and will include 7 visits.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 50-75 years old (at time of screening)

  • Body mass index (BMI) 18.5 to < 30 kg/m2

  • Willing to consume grape and control powder during study periods, and refrain fromeating grapes and certain other polyphenol-rich foods and beverages during the study

  • Do not fit any exclusion criteria

Exclusion

Exclusion Criteria:

  • <50 years old and >75 years old

  • BMI <18.5 and ≥ 30 kg/m2 or body weight < 110 pounds

  • Experienced >10% weight change in the past 4 weeks

  • Elevated fasting glucose levels (fasting glucose higher than 126 mg/dL) andtriglycerides greater than 500 mg/dL

  • Self-reported and/or physician-diagnosed history of diabetes mellitus, coronaryheart disease, stroke, renal or liver disease, cancer, eating disorders, certainsevere and/or relapsing/remitting autoimmune, inflammatory, or metabolic diseases,chronic infections, scleroderma, blood clotting disorders, intravenous drug use, orcurrent pregnancy or lactation

  • Allergy to grapes or any ingredients in the grape or control powders

  • Implanted medical device (e.g., pacemaker) or other health condition that wouldprevent measurement of body composition by bioelectrical impedance

  • Currently taking lipid-lowering medications (e.g., statins, fibrates),glucose-regulating medications, anti-inflammatory medications (e.g., non-steroidalanti-inflammatory drugs (NSAIDs), corticosteroids), or medications that primarilyaffect blood clotting (e.g., warfarin), long-term antibiotics in the last 3 months,active use of probiotics during the intervention

  • Active smoker

Study Design

Total Participants: 28
Treatment Group(s): 2
Primary Treatment: Freeze-dried whole grape powder
Phase:
Study Start date:
July 25, 2025
Estimated Completion Date:
September 30, 2027

Connect with a study center

  • Department of Nutritional Sciences

    Storrs, Connecticut 06269
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.